Oncology Biosimilars Market to become worth US$17,478.2 million by 2025 - TMR
Albany, New York, Dec. 05, 2018 (GLOBE NEWSWIRE) -- The TMR report finds that the global oncology biosimilars market would rise at a phenomenal 27.5% CAGR from 2017 and 2025. The report valued the market at US$2.1 mn in 2016. By 2025, it expects the market …